Peter Kip
Brigham and Women's Hospital
12 Papers
13 Citations
Peter Kip is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Vein graft disease & Medicine. The author has an hindex of 3, co-authored 12 publications. Previous affiliations of Peter Kip include Leiden University Medical Center & Harvard University.
Chat about Author
Papers
Deficiency of the TLR4 analogue RP105 aggravates vein graft disease by inducing a pro-inflammatory response
Anouk Wezel,Anouk Wezel,Margreet R. de Vries,Johanna M. Maassen,Peter Kip,Erna Peters,J.C. Karper,Johan Kuiper,Ilze Bot,Ilze Bot,Paul H.A. Quax +10 more
TL;DR: In conclusion, aggravated vein graft disease caused by RP105 deficiency results from an increased local inflammatory response.
Preoperative Protein or Methionine Restriction Preserves Wound Healing and Reduces Hyperglycemia.
Kaspar Trocha,Peter Kip,Michael R MacArthur,Sarah J. Mitchell,Alban Longchamp,Jose Humberto Treviño-Villarreal,Ming Tao,Miriam A. Bredella,Karen De Amorim Bernstein,James R. Mitchell,C.K. Ozaki +10 more
TL;DR: Short-term dietary preconditioning with PR or MR did not impair wound healing in nondiabetic or diabetic mice, however, both regimens reduced preoperative hyperglycemia in diabetic mice.
18
Periprocedural Hydrogen Sulfide Therapy Improves Vascular Remodeling and Attenuates Vein Graft Disease.
Peter Kip,Peter Kip,Peter Kip,Ming Tao,Kaspar Trocha,Kaspar Trocha,Michael R MacArthur,H.A.B. Peters,Sarah J. Mitchell,Charlotte G. Mann,Thijs J. Sluiter,Thijs J. Sluiter,Thijs J. Sluiter,Jonathan Jung,Jonathan Jung,Suzannah Patterson,Paul H.A. Quax,Margreet R. de Vries,James R. Mitchell,C. Keith Ozaki +19 more
TL;DR: Local gel‐based treatment with the hydrogen sulfide‐donor GYY stands as a translatable therapy to improve VG durability and arterial remodeling after injury.
15
Intracellular H2S production is an autophagy-dependent adaptive response to DNA damage.
Xiaofeng Jiang,Michael R MacArthur,J. Humberto Treviño-Villarreal,Peter Kip,Peter Kip,Peter Kip,C. Keith Ozaki,Sarah J. Mitchell,James R. Mitchell,James R. Mitchell +9 more
TL;DR: In this paper, the authors performed a small-molecule screen and identified genotoxic agents, including cancer chemotherapy drugs, as activators of intracellular H2S levels.
13
Insights From a Short-Term Protein-Calorie Restriction Exploratory Trial in Elective Carotid Endarterectomy Patients.
Peter Kip,Peter Kip,Peter Kip,Kaspar Trocha,Kaspar Trocha,Ming Tao,James J. O'Leary,Jack Ruske,Jennifer M Giulietti,Jose H Trevino-Villareal,Michael R MacArthur,Andrew Bolze,M. Furkan Burak,M. Furkan Burak,Suzannah Patterson,Karen J. Ho,Rachel N. Carmody,Raul J. Guzman,James R. Mitchell,C. Keith Ozaki +19 more
TL;DR: Although carotid endarterectomy patients held low enthusiasm for a 3-day preoperative inpatient stay, there were no adverse effects in this small cohort and future translational endeavors into dietary preconditioning of vascular surgery patients should focus on outpatient approaches.
13